Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cyclo(RLsKDK) | 1975145-82-4 | 98.9% | 727.85 | 5 MG
SDP

Supplier:  Medchemexpress LLC HYP16765MG

Encompass_Preferred

cyclo(RLsKDK) (BK-1361) is a specific inhibitor of metalloproteinase ADAM8 with an IC50 value of 182 nM. It demonstrates potential applications in the treatment of inflammatory diseases and cancer.

  • Inhibits metalloproteinase ADAM8.
  • Promotes ADAM8 activation and CD23 shedding.
  • Increases activity of pro-ADAM8.
  • Promotes growth of Panc1_ctrl and Panc1_A8 cells.
  • Induces ERK1/2 phosphorylation in Panc1_ctrl and Panc1_A8 cells.
  • Significantly reduces tumor load in mice with Panc1_ctrl or Panc1_A8 cell implants.
  • Improves survival rate of pancreatic ductal adenocarcinoma (PDAC) mice.
  • Reduces soluble ADAM8 (sADAM8) content and pERK1/2 activation in PDAC mice.
  • Decreases PDAC metastasis in the liver and lungs of PDAC mice.

Catalog No. 50-004-24364


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.